Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

60 Degrees Pharmaceuticals stock

SXTP
US83006G1040

Price

1.01
Today +/-
-0.07
Today %
-6.70 %

60 Degrees Pharmaceuticals stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the 60 Degrees Pharmaceuticals stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the 60 Degrees Pharmaceuticals stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the 60 Degrees Pharmaceuticals stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze 60 Degrees Pharmaceuticals's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

60 Degrees Pharmaceuticals Stock Price History

Date60 Degrees Pharmaceuticals Price
12/4/20241.01 undefined
12/3/20241.08 undefined
12/2/20241.07 undefined
11/29/20241.06 undefined
11/27/20241.09 undefined
11/26/20241.01 undefined
11/25/20241.18 undefined
11/22/20240.90 undefined
11/21/20240.87 undefined
11/20/20240.92 undefined
11/19/20240.92 undefined
11/18/20240.87 undefined
11/15/20240.90 undefined
11/14/20240.95 undefined
11/13/20240.98 undefined
11/12/20241.01 undefined
11/11/20240.99 undefined
11/8/20240.95 undefined
11/7/20241.07 undefined
11/6/20240.98 undefined

60 Degrees Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into 60 Degrees Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by 60 Degrees Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects 60 Degrees Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of 60 Degrees Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into 60 Degrees Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing 60 Degrees Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on 60 Degrees Pharmaceuticals’s growth potential.

60 Degrees Pharmaceuticals Revenue, EBIT and net profit per share

Date60 Degrees Pharmaceuticals Revenue60 Degrees Pharmaceuticals EBIT60 Degrees Pharmaceuticals Net Income
2026e2.12 M undefined-8.73 M undefined-563,040 undefined
2025e2.62 M undefined-6.9 M undefined-4.25 M undefined
2024e930,750 undefined-8.09 M undefined-11.24 M undefined
2023253,570 undefined-5.15 M undefined-3.99 M undefined
2022511,210 undefined-1.75 M undefined-6.18 M undefined
20216.35 M undefined-1.12 M undefined-4.25 M undefined
20202.18 M undefined-786,240 undefined-3.03 M undefined

60 Degrees Pharmaceuticals Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20202021202220232024e2025e2026e
2600022
-200.00-----
50.0083.33---250.00250.00
1500000
-3-4-6-3-11-40
-33.3350.00-50.00266.67-63.64-
5.570.460.460.33000
-------
Details

Keystats

Revenue and Growth

The 60 Degrees Pharmaceuticals Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the 60 Degrees Pharmaceuticals is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (k)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (k)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2020202120222023
       
0.190.120.262.14
859.43146.3645.97231.33
0000
1.040.690.520.47
0.350.230.274.4
2.441.181.17.24
73.41107.6233.9571.28
0000
0000
80.23109.24164.26227.26
0000
9.5500242.65
163.19216.86198.21541.19
2.611.391.37.78
       
0.84.9809.86
005.1627.46
-18.38-22.63-28.82-32.58
80.4575.8473.71135.56
0000
-17.5-17.58-23.584.87
1.380.590.760.51
046.81313.65
0.0601.822.31
0000
0021.330.01
1.430.6423.922.84
19.1418.741.270.15
0000
103.01167.742550
19.2418.911.530.15
20.6819.5525.452.99
3.181.971.877.86
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of 60 Degrees Pharmaceuticals provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand 60 Degrees Pharmaceuticals's financial health and stability.

Assets

60 Degrees Pharmaceuticals's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that 60 Degrees Pharmaceuticals must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of 60 Degrees Pharmaceuticals after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into 60 Degrees Pharmaceuticals's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (k)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (k)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
202020212022
-3-4-6
000
000
223
001,000
000
000
00-1
000
000
000
000
001,000
000
001,000
---
000
000
-0.24-0.68-1.07
000

60 Degrees Pharmaceuticals stock margins

The 60 Degrees Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of 60 Degrees Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for 60 Degrees Pharmaceuticals.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the 60 Degrees Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the 60 Degrees Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the 60 Degrees Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the 60 Degrees Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the 60 Degrees Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the 60 Degrees Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the 60 Degrees Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

60 Degrees Pharmaceuticals Margin History

60 Degrees Pharmaceuticals Gross margin60 Degrees Pharmaceuticals Profit margin60 Degrees Pharmaceuticals EBIT margin60 Degrees Pharmaceuticals Profit margin
2026e-87.15 %-411.03 %-26.51 %
2025e-87.15 %-263.01 %-161.89 %
2024e-87.15 %-869.48 %-1,207.34 %
2023-87.15 %-2,032.81 %-1,572.12 %
202215.42 %-342.41 %-1,209.23 %
202186.61 %-17.69 %-66.93 %
202067.77 %-36.04 %-139.08 %

60 Degrees Pharmaceuticals Stock Sales Revenue, EBIT, Earnings per Share

The 60 Degrees Pharmaceuticals earnings per share therefore indicates how much revenue 60 Degrees Pharmaceuticals has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue 60 Degrees Pharmaceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates 60 Degrees Pharmaceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of 60 Degrees Pharmaceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating 60 Degrees Pharmaceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

60 Degrees Pharmaceuticals Revenue, EBIT and net profit per share

Date60 Degrees Pharmaceuticals Sales per Share60 Degrees Pharmaceuticals EBIT per share60 Degrees Pharmaceuticals Earnings per Share
2026e0.92 undefined0 undefined-0.24 undefined
2025e1.14 undefined0 undefined-1.85 undefined
2024e0.4 undefined0 undefined-4.89 undefined
20230.77 undefined-15.62 undefined-12.08 undefined
20221.1 undefined-3.77 undefined-13.32 undefined
202113.69 undefined-2.42 undefined-9.16 undefined
20200.39 undefined-0.14 undefined-0.54 undefined

60 Degrees Pharmaceuticals business model

60 Degrees Pharmaceuticals is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

60 Degrees Pharmaceuticals Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

60 Degrees Pharmaceuticals historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

60 Degrees Pharmaceuticals shares outstanding

The number of shares was 60 Degrees Pharmaceuticals in 2023 — This indicates how many shares 330,020 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue 60 Degrees Pharmaceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates 60 Degrees Pharmaceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of 60 Degrees Pharmaceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating 60 Degrees Pharmaceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

60 Degrees Pharmaceuticals stock splits

In 60 Degrees Pharmaceuticals's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for 60 Degrees Pharmaceuticals.

60 Degrees Pharmaceuticals latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2024-0.72 -0.93  (-29.33 %)2024 Q3
6/30/2024-2.85 -4.23  (-48.37 %)2024 Q2
3/31/2024-1.84 0.36  (119.61 %)2024 Q1
12/31/2023-2.51 -4.32  (-72.17 %)2023 Q4
9/30/202311.63 9.24  (-20.54 %)2023 Q3
1

60 Degrees Pharmaceuticals shareholders

%
Name
Stocks
Change
Date
4.18078 % Knight Therapeutics, Inc.96,15805/17/2024
2.76313 % Dow (Geoffrey S)63,5521,4165/17/2024
1.04687 % Xu (Cheryl)24,0785,0008/27/2024
0.64104 % Miller (Tyrone)14,7441,2505/17/2024
0.16357 % Virtu Americas LLC3,762-1,1986/30/2024
0.13770 % Geode Capital Management, L.L.C.3,1672,5766/30/2024
0.12491 % UBS Financial Services, Inc.2,8732,8736/30/2024
0.10430 % HRT Financial LP2,3992,3996/30/2024
0.06230 % Two Sigma Investments, LP1,433-5836/30/2024
0.05074 % Allen (Charles W)1,1673345/17/2024
1
2
3

60 Degrees Pharmaceuticals Executives and Management Board

Mr. Tyrone Miller

(49)
60 Degrees Pharmaceuticals Chief Financial Officer
Compensation 148,672

Dr. Geoffrey Dow

(50)
60 Degrees Pharmaceuticals President, Chief Executive Officer, Director
Compensation 54,510

Dr. Bryan Smith

(57)
60 Degrees Pharmaceuticals Chief Medical Officer

Ms. Cheryl Xu

(55)
60 Degrees Pharmaceuticals Director Nominee

Mr. Charles Allen

(47)
60 Degrees Pharmaceuticals Independent Director Nominee
1
2

Most common questions regarding 60 Degrees Pharmaceuticals

What is the P/E ratio of 60 Degrees Pharmaceuticals 2024?

The 60 Degrees Pharmaceuticals P/E ratio is -0.03.

What is the P/S ratio of 60 Degrees Pharmaceuticals 2024?

The 60 Degrees Pharmaceuticals P/S ratio is 0.36.

What is the Quality Investing of 60 Degrees Pharmaceuticals?

The Quality Investing for 60 Degrees Pharmaceuticals is 3/10.

What is the revenue of 60 Degrees Pharmaceuticals 2024?

The expected 60 Degrees Pharmaceuticals revenue is 930,750 USD.

How high is the profit of 60 Degrees Pharmaceuticals 2024?

The expected 60 Degrees Pharmaceuticals profit is -11.24 M USD.

What is the business model of 60 Degrees Pharmaceuticals

No history available for 60 Degrees Pharmaceuticals.

What is the 60 Degrees Pharmaceuticals dividend?

60 Degrees Pharmaceuticals pays a dividend of 0 USD distributed over payouts per year.

How often does 60 Degrees Pharmaceuticals pay dividends?

The dividend cannot currently be calculated for 60 Degrees Pharmaceuticals or the company does not pay out a dividend.

What is the 60 Degrees Pharmaceuticals ISIN?

The ISIN of 60 Degrees Pharmaceuticals is US83006G1040.

What is the 60 Degrees Pharmaceuticals ticker?

The ticker of 60 Degrees Pharmaceuticals is SXTP.

How much dividend does 60 Degrees Pharmaceuticals pay?

Over the past 12 months, 60 Degrees Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 60 Degrees Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of 60 Degrees Pharmaceuticals?

The current dividend yield of 60 Degrees Pharmaceuticals is .

When does 60 Degrees Pharmaceuticals pay dividends?

60 Degrees Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of 60 Degrees Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 60 Degrees Pharmaceuticals located?

60 Degrees Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von 60 Degrees Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 60 Degrees Pharmaceuticals from 12/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/5/2024.

When did 60 Degrees Pharmaceuticals pay the last dividend?

The last dividend was paid out on 12/5/2024.

What was the dividend of 60 Degrees Pharmaceuticals in the year 2023?

In the year 2023, 60 Degrees Pharmaceuticals distributed 0 USD as dividends.

In which currency does 60 Degrees Pharmaceuticals pay out the dividend?

The dividends of 60 Degrees Pharmaceuticals are distributed in USD.

All fundamentals about 60 Degrees Pharmaceuticals

Our stock analysis for 60 Degrees Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 60 Degrees Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.